期刊文献+

难治性高血压的病因和治疗研究进展 被引量:39

Progress in Research of Etiology and Therapy of Resistant Hypertension
下载PDF
导出
摘要 难治性高血压是一种特殊类型的高血压,危害较大。研究和治疗难治性高血压对患者有重要的临床意义。难治性高血压有多种病因。成功的治疗不仅需要治疗性生活方式的改变,同时也需要诊断和适当治疗继发性高血压的原发疾病,并使用有效的多种药物联合治疗与介入治疗的方法。本文综述了难治性高血压的病因和治疗方面的进展。 Resistant hypertension, a special type of hypertension, is harmful to patients. It is of great clinical signifi- cance to research resistant hypertension. Resistant hypertension is multifactorial in etiology. Successful treatment requires not on- ly a therapeutic lifestyle changes but also diagnosis, appropriate treatment of secondary hypertension and use of effective muhidrug regimens and interventional therapy. This article reviews the relevant progress in etiology and therapy of resistant hypertension in recent years.
作者 陈莉 程文立
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第26期2974-2977,共4页 Chinese General Practice
关键词 难治性高血压 病因 治疗 Resistant hypertension Etiology Therapy
  • 相关文献

参考文献28

  • 1Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [ J ]. JAMA, 2003, 289 (19): 2560-2572.
  • 2Mancia G, De Backer G, Dominiezak A, et al. 2007 Guidelines for the Management of Arterial Hypertension : The Task Force for the Man- agement of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [J]. J Hy- pertens, 2007, 25 (6): 1105-1187.
  • 3刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 4Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diag- nosis, evaluation, and treatment. A scientific statement from the Amer- ican Heart Association Professional Education Committee of the Council for High Blood Pressure Research [ J ]. Hypertension, 2008, 51 (6): 1403 -1419.
  • 5刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6936
  • 6Leenen FH, Nwachuku CE, Black HR, et al. Clinical events in high - risk hypertensive patients randomly assigned to calcium channel bloc- ker versus angiotensin - converting enzyme inhibitor in the antihypertens- ive and lipid -lowering treatment to prevent heart attack trial [ J]. Hy- pertension, 2006, 48 (3): 374-384.
  • 7Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive pa- tients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J]. Lancet, 2004, 363 (9426) : 2022 -2031.
  • 8Hannila - Handelberg T, Kontula K, Tikkanen I, et al. Common vari- ants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hyperten- sion [J]. BMC Med Genet, 2005, 6: 4.
  • 9Givens RC, Lin YS, Dowling AL, et al. CYP3A.5 genotype predicts renal CYP3A activity and blood pressure in healthy adults [ J]. J Appl Physiol, 2003, 95 (3) : 1297 -1300.
  • 10Picketing TG, Hall JE, Appel LJ, et 81. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the A- merican Heart Association Council on High Blood Pressure Research [J]. Circulation. 2005. 111 (5): 697-716.

二级参考文献38

共引文献9543

同被引文献251

引证文献39

二级引证文献153

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部